Christopher K. Breuer

Vessel bioengineering.

Regenerative implants for cardiovascular tissue engineering.

Characterization of evolving biomechanical properties of tissue engineered vascular grafts in the arterial circulation.

Evaluation of remodeling process in small-diameter cell-free tissue-engineered arterial graft.

Comparison of a Closed System to a Standard Open Technique for Preparing Tissue Engineered Vascular Grafts.

Targeted imaging of matrix metalloproteinase activity in the evaluation of remodeling tissue-engineered vascular grafts implanted in a growing lamb model.

A hypothesis-driven parametric study of effects of polymeric scaffold properties on tissue engineered neovessel formation.

Comparison of the biological equivalence of two methods for isolating bone marrow mononuclear cells for fabricating tissue-engineered vascular grafts.

Well-organized neointima of large-pore poly(L-lactic acid) vascular graft coated with poly(L-lactic-co-ε-caprolactone) prevents calcific deposition compared to small-pore electrospun poly(L-lactic acid) graft in a mouse aortic implantation model.

Biomechanical diversity despite mechanobiological stability in tissue engineered vascular grafts two years post-implantation.

The innate immune system contributes to tissue-engineered vascular graft performance.

Development of small diameter nanofiber tissue engineered arterial grafts.

Hemodynamic Characterization of a Mouse Model for Investigating the Cellular and Molecular Mechanisms of Neotissue Formation in Tissue-Engineered Heart Valves.

C-Cell Neoplasia in Asymptomatic Carriers of RET Mutation in Extracellular Cysteine-Rich and Intracellular Tyrosine Kinase Domain.

Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model.

Influence of Posttransplant Lymphoproliferative Disorder on Survival in Children After Heart Transplantation.

A mouse model of endocardial fibroelastosis.

Effect of cell seeding on neotissue formation in a tissue engineered trachea.

Cardiovascular Tissue Engineering: Preclinical Validation to Bedside Application.

Long-Term Functional Efficacy of a Novel Electrospun Poly(Glycerol Sebacate)-Based Arterial Graft in Mice.

TGF-β receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation.

Novel Bioresorbable Vascular Graft With Sponge-Type Scaffold as a Small-Diameter Arterial Graft.

Setting Global Standards for Stem Cell Research and Clinical Translation: The 2016 ISSCR Guidelines.

Pilot Mouse Study of 1 mm Inner Diameter (ID) Vascular Graft Using Electrospun Poly(ester urea) Nanofibers.

Clinical Translation of Tissue Engineered Trachea Grafts.

Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model.

Impaired von Willebrand factor adhesion and platelet response in thrombospondin-2 knockout mice.

Fast-degrading bioresorbable arterial vascular graft with high cellular infiltration inhibits calcification of the graft.

Objective characterization of airway dimensions using image processing.

Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model.

Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model.

Tropoelastin inhibits intimal hyperplasia of mouse bioresorbable arterial vascular grafts.

Intravascular Ultrasound Characterization of a Tissue-Engineered Vascular Graft in an Ovine Model.

Endoscopic management of tissue-engineered tracheal graft stenosis in an ovine model.

Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts.

Stress Analysis-Driven Design of Bilayered Scaffolds for Tissue-Engineered Vascular Grafts.

Designing a tissue-engineered tracheal scaffold for preclinical evaluation.

Tissue-Engineered Heart Valves: A Call for Mechanistic Studies.

Tissue-engineered Vascular Grafts in Children With Congenital Heart Disease: Intermediate Term Follow-up.

Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation.

Bone marrow-derived mononuclear cell seeded bioresorbable vascular graft improves acute graft patency by inhibiting thrombus formation via platelet adhesion.

Angiotensin II receptor I blockade prevents stenosis of tissue engineered vascular grafts.

Magnetic Resonance Imaging of Shear Stress and Wall Thickness in Tissue-Engineered Vascular Grafts.

Clinical validation and reproducibility of endoscopic airway measurement in pediatric aerodigestive evaluation.

Implantation of VEGF-functionalized cell-free vascular grafts: regenerative and immunological response.

Mouse Model of Tracheal Replacement With Electrospun Nanofiber Scaffolds.

Factors Influencing Poor Outcomes in Synthetic Tissue-Engineered Tracheal Replacement.

Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model.

Differential outcomes of venous and arterial tissue engineered vascular grafts highlight the importance of coupling long-term implantation studies with computational modeling.

Optimization of Tissue-Engineered Vascular Graft Design Using Computational Modeling.

Degradation and evaluation of polycaprolactone, poly(ε-caprolactone-co-L-lactide), and poly-L-lactic acid as scaffold sealant polymers for murine tissue-engineered vascular grafts.

Deconstructing tissue engineered trachea: Assessing the role of synthetic scaffolds, segmental replacement and cell seeding on graft performance.

Different degradation rates of nanofiber vascular grafts in small and large animal models.

Fetal Transcatheter Trileaflet Heart Valve Hemodynamics: Implications of Scaling on Valve Mechanics and Turbulence.

A computational bio-chemo-mechanical model of in vivo tissue-engineered vascular graft development.

Spontaneous reversal of stenosis in tissue-engineered vascular grafts.

The evaluation of a tissue-engineered cardiac patch seeded with hips derived cardiac progenitor cells in a rat left ventricular model.

Spatial and Temporal Analysis of Host Cells in Tracheal Graft Implantation.

The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model.

Electrospun Tissue-Engineered Arterial Graft Thickness Affects Long-Term Composition and Mechanics.

Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation.

Effects of Braiding Parameters on Tissue Engineered Vascular Graft Development.

Tissue Engineered Vascular Graft Recipient Interleukin 10 Status Is Critical for Preventing Thrombosis.

Evaluating the Longevity of the Fontan Pathway.

Biology and Biomechanics of the Heart Valve Extracellular Matrix.

Tissue engineering: Relevance to neonatal congenital heart disease.

Current Challenges and Solutions to Tissue Engineering of Large-scale Cardiac Constructs.

Sex and Tamoxifen confound murine experimental studies in cardiovascular tissue engineering.

Tracheal Macrophages During Regeneration and Repair of Long-Segment Airway Defects.

Regeneration of partially decellularized tracheal scaffolds in a mouse model of orthotopic tracheal replacement.

Imatinib attenuates neotissue formation during vascular remodeling in an arterial bioresorbable vascular graft.

On the shape and structure of the murine pulmonary heart valve.

Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients.

TGFβR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts.

Publisher Correction: Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients.

Modulation of Synthetic Tracheal Grafts with Extracellular Matrix Coatings.

The lysosomal trafficking regulator is necessary for normal wound healing.

Fibrocytes: A Critical Review and Practical Guide.

Antibody-suppressor CXCR5 CD8 T cellular therapy ameliorates antibody-mediated rejection following kidney transplant in CCR5 KO mice.

The Potential Role of Regenerative Medicine on the Future Management of Hypoplastic Left Heart Syndrome.

Tissue engineered vascular grafts transform into autologous neovessels capable of native function and growth.

A Multimodal Approach to Quantify Chondrocyte Viability for Airway Tissue Engineering.

Tissue-engineered composite tracheal grafts create mechanically stable and biocompatible airway replacements.

Monocyte Recruitment for Vascular Tissue Regeneration.

Rapid Regeneration of a Neoartery with Elastic Lamellae.

Tamoxifen reduces silicone implant capsule formation in a mouse model.

Computational analysis of serum-derived extracellular vesicle miRNAs in juvenile sheep model of single stage Fontan procedure.

Tissue Engineering of Vascular Grafts: A Case Report From Bench to Bedside and Back.

Implanted Tissue-Engineered Vascular Graft Cell Isolation with Single-Cell RNA Sequencing Analysis.

Patch Materials for Pulmonary Artery Arterioplasty and Right Ventricular Outflow Tract Augmentation: A Review.

Regeneration of tracheal neotissue in partially decellularized scaffolds.

Functional mechanical behavior of the murine pulmonary heart valve.

Assessing the Biocompatibility and Regeneration of Electrospun-Nanofiber Composite Tracheal Grafts.

Evaluation of tissue-engineered human acellular vessels as a Blalock-Taussig-Thomas shunt in a juvenile primate model.

Development of Novel Sutureless Balloon Expandable Fetal Heart Valve Device Using Absorbable Polycaprolactone Leaflets.

CXCR5 + CD8 + T Cell-mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition.

A Fluid-Solid-Growth Solver for Cardiovascular Modeling.

Quantification of Skeletal Muscle Perfusion in Peripheral Artery Disease Using F-Sodium Fluoride Positron Emission Tomography Imaging.

Tissue engineered vascular grafts are resistant to the formation of dystrophic calcification.

Antibody-Suppressor CXCR5+CD8+ T Cells Are More Potent Regulators of Humoral Alloimmunity after Kidney Transplant in Mice Compared to CD4+ Regulatory T Cells.